🗂️ Navigation

UMC-WHO VigiBase

The WHO global database of individual case safety reports.

Visit Website →

Overview

VigiBase is the WHO's global database of individual case safety reports (ICSRs). It is the largest and most comprehensive database of its kind, containing millions of reports of suspected adverse effects of medicines. VigiBase is used by national pharmacovigilance centers, researchers, and other stakeholders to identify potential drug safety signals and to support decision-making.

✨ Key Features

  • Global database of ICSRs
  • Signal detection and analysis tools
  • Data sharing and collaboration
  • Supports national pharmacovigilance centers
  • Managed by the Uppsala Monitoring Centre (UMC)

🎯 Key Differentiators

  • The largest global database of ICSRs
  • Managed by the WHO's Uppsala Monitoring Centre
  • Strong focus on global collaboration and data sharing

Unique Value: The world's largest and most comprehensive database of adverse event reports, providing a unique resource for global pharmacovigilance.

🎯 Use Cases (4)

Global signal detection and analysis Pharmacovigilance research Supporting national drug safety monitoring Informing regulatory decisions

✅ Best For

  • Global pharmacovigilance and signal detection

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Organizations looking for a system to manage their own internal adverse event cases and regulatory submissions

🏆 Alternatives

FAERS (FDA Adverse Event Reporting System) EudraVigilance

Offers a more global perspective compared to national or regional databases.

💻 Platforms

Web

🔌 Integrations

National pharmacovigilance systems

🛟 Support Options

  • ✓ Email Support
  • ✓ Dedicated Support (NA tier)

🔒 Compliance & Security

✓ GDPR

💰 Pricing

Contact for pricing
Free Tier Available

Free tier: Access is primarily for national pharmacovigilance centers and researchers.

Visit UMC-WHO VigiBase Website →